100
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival rates

, , , , , , & ORCID Icon show all
Pages 1711-1720 | Received 15 Sep 2020, Accepted 28 Jan 2021, Published online: 24 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Konrad J. Cios, Taha I. Huda, Rachel A. Eakins, Moody M. Mihyu & George Blanck. (2022) Specific TCR V–J gene segment recombinations leading to the identification pan-V–J CDR3s associated with survival distinctions: diffuse large B-cell lymphoma. Leukemia & Lymphoma 63:6, pages 1314-1322.
Read now

Articles from other publishers (3)

George Angelakakis, Karisa S. Serraneau, Vayda R. Barker, Blake M. Callahan, Wei Lue Tong, Saif Zaman, Taha I. Huda & George Blanck. (2022) TCR gene segment usage and HLA alleles that are associated with cancer survival rates also represent racial disparities. International Journal of Immunogenetics 50:2, pages 41-47.
Crossref
Taha I. Huda, Michael J. Diaz, Etienne C. Gozlan, Andrea Chobrutskiy, Boris I. Chobrutskiy & George Blanck. (2022) Immunogenomics Parameters for Patient Stratification in Alzheimer’s Disease. Journal of Alzheimer's Disease 88:2, pages 619-629.
Crossref
Brooke Mcbreairty, Boris Chobrutskiy, Andrea Chobrutskiy, Etienne Gozlan, Michael Diaz & George Blanck. (2022) Immune receptor CDR3 chemical features that preserve sequence information are highly efficient in reflecting survival distinctions: A pan‑cancer analysis. Biomedical Reports 17:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.